Eris Lifesciences - Quaterly Results

03 May 2022 Evaluate
The Revenue for the quarter ended  March 2022 of Rs. 2821.42 millions grew by 9.85 % from Rs. 2568.49 millions.Good  Net Profit growth of 25.03% reported above the corresponding previous quarter figure of Rs. 693.48 millions to Rs. 867.09 millioins.Operating profit for the quarter ended March 2022 rose to 1106.76 millions as compared to 967.68 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2821.42 2568.49 9.85 12157.30 11088.34 9.64 12157.30 11088.34 9.64
Other Income 90.52 27.48 229.40 289.89 99.98 189.95 289.89 99.98 189.95
PBIDT 1106.76 967.68 14.37 5129.84 4273.12 20.05 5129.84 4273.12 20.05
Interest 9.77 1.99 390.95 29.91 7.78 284.45 29.91 7.78 284.45
PBDT 1096.99 965.69 13.60 5099.93 4265.34 19.57 5099.93 4265.34 19.57
Depreciation 150.70 101.38 48.65 514.55 376.40 36.70 514.55 376.40 36.70
PBT 946.29 864.31 9.49 4585.38 3888.94 17.91 4585.38 3888.94 17.91
TAX 79.20 170.83 -53.64 413.46 382.89 7.98 413.46 382.89 7.98
Deferred Tax 6.24 4.72 32.20 -388.26 -318.95 21.73 -388.26 -318.95 21.73
PAT 867.09 693.48 25.03 4171.92 3506.05 18.99 4171.92 3506.05 18.99
Equity 135.93 135.78 0.11 135.93 135.78 0.11 135.93 135.78 0.11
PBIDTM(%) 39.23 37.68 4.12 42.20 38.54 9.49 42.20 38.54 9.49

Eris Lifesciences Share Price

1386.30 -31.40 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×